Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Using spectral CT scans for cervical cancer radiotherapy

Official title: The Clinical Research of Spectral CT in Radiotherapy for Cervical Cancer

Run by Peking Union Medical College Hospital · NCT06433817 · Data updated 2026-11-12

This study is testing if special CT scans can help improve treatment planning and monitoring for patients with cervical cancer who are receiving chemotherapy and radiation.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment150 (estimated)
SponsorPeking Union Medical College Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMay 22, 2024
Main results expectedMay 22, 2026
Study endsDecember 31, 2026
Registry record updatedMay 30, 2024
Trial IDNCT06433817 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients diagnosed with cervical cancer who are receiving concurrent chemoradiotherapy.

Probably not a fit

Patients who have not undergone spectral CT scans or those with a history of allergy to intravenous contrast may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the application of spectral computed tomography (CT) in the context of radiotherapy for patients with cervical cancer. It involves patients who have been diagnosed with cervical cancer and are undergoing concurrent chemoradiotherapy, with spectral CT scans being performed during both the arterial and venous phases. The study seeks to evaluate how spectral CT can enhance treatment planning and monitoring in this patient population.

Why it matters

Potential benefit: If successful, this approach could improve the precision of radiotherapy for cervical cancer patients, potentially leading to better treatment outcomes.

How similar studies have gone: While the application of spectral CT in radiotherapy is a relatively novel approach, there have been some preliminary studies suggesting its potential benefits in similar contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All patients were confirmed cervical cancer by pathology
2. patients were treated with concurrent chemoradiotherapy
3. Spectral CT scans acquisition performed during the arterial phase and venous phase
4. All the patients underwent a 18F-FDG PET/CT before treatment

Exclusion Criteria:

1. CT without spectral scans
2. History of allergy to intravenous contrast
3. Pregnant or potentially pregnant female subjects

Where it's running

  • Peking Union Medical College Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.